Business

November 14, 2013

Durham’s Chimerix reports third-quarter earnings that beat Wall Street estimates

Durham antiviral drug developer Chimerix reported third-quarter earnings Thursday that beat Wall Street estimates.

Related content

Comments

Videos

Editor's Choice Videos